tiprankstipranks
Trending News
More News >
Eledon Pharmaceuticals (ELDN)
NASDAQ:ELDN
US Market
Advertisement

Eledon Pharmaceuticals (ELDN) Ratios

Compare
901 Followers

Eledon Pharmaceuticals Ratios

ELDN's free cash flow for Q1 2025 was $0.00. For the 2025 fiscal year, ELDN's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
8.12 14.41 9.19 20.07 46.57
Quick Ratio
8.12 14.41 9.19 20.07 46.05
Cash Ratio
0.42 1.18 8.71 19.28 45.99
Solvency Ratio
0.35 -0.49 -10.12 -5.24 -3.43
Operating Cash Flow Ratio
-4.70 -10.15 -4.39 -6.57 -6.13
Short-Term Operating Cash Flow Coverage
0.00 0.00 -78.30 -78.36 -105.64
Net Current Asset Value
$ 16.83M$ -25.73M$ 50.91M$ 81.79M$ 109.04M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
0.02 0.05 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
0.02 0.05 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
2.88 12.36 1.10 1.04 1.03
Debt Service Coverage Ratio
0.00 0.00 -240.03 -92.98 -157.14
Interest Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
0.00 0.00 0.01 <0.01 <0.01
Interest Debt Per Share
0.01 0.02 0.05 0.05 0.10
Net Debt to EBITDA
0.06 0.04 0.64 2.29 4.95
Profitability Margins
Gross Profit Margin
58.85%0.00%0.00%0.00%-52.50%
EBIT Margin
-39809.37%0.00%0.00%0.00%-19345.83%
EBITDA Margin
-45695.83%0.00%0.00%0.00%-19193.33%
Operating Profit Margin
-45682.81%0.00%0.00%0.00%-15387.50%
Pretax Profit Margin
7851.04%0.00%0.00%0.00%-19345.83%
Net Profit Margin
7626.56%0.00%0.00%0.00%-19009.17%
Continuous Operations Profit Margin
7626.56%0.00%0.00%0.00%-19009.17%
Net Income Per EBT
97.14%100.00%99.47%93.61%98.26%
EBT Per EBIT
-17.19%93.78%-1035.50%99.98%125.72%
Return on Assets (ROA)
10.10%-45.28%-94.30%-20.23%-11.57%
Return on Equity (ROE)
16.31%-559.46%-103.94%-21.04%-11.97%
Return on Capital Employed (ROCE)
-66.86%-50.49%9.84%-22.19%-9.48%
Return on Invested Capital (ROIC)
-68.59%-50.26%9.71%-20.68%-9.30%
Return on Tangible Assets
13.01%-71.15%-144.86%-38.55%-19.64%
Earnings Yield
7.24%-91.00%-268.66%-52.80%-102.05%
Efficiency Ratios
Receivables Turnover
0.27 0.00 0.00 0.00 1.09
Payables Turnover
0.01 0.00 0.17 0.11 0.13
Inventory Turnover
0.00 0.00 0.00 0.00 0.14
Fixed Asset Turnover
0.25 0.00 0.00 0.00 0.87
Asset Turnover
<0.01 0.00 0.00 0.00 <0.01
Working Capital Turnover Ratio
<0.01 0.00 0.00 0.00 <0.01
Cash Conversion Cycle
-25.60K 0.00 -2.15K -3.39K 177.02
Days of Sales Outstanding
1.34K 0.00 0.00 0.00 334.58
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 2.57K
Days of Payables Outstanding
26.94K 0.00 2.15K 3.39K 2.72K
Operating Cycle
1.34K 0.00 0.00 0.00 2.90K
Cash Flow Ratios
Operating Cash Flow Per Share
-0.84 -1.61 -1.99 -1.95 -10.48
Free Cash Flow Per Share
-0.84 -1.61 -1.99 -1.95 -10.48
CapEx Per Share
0.00 0.00 0.00 0.00 0.00
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
0.00 0.00 0.00 0.00 -608.48
Capital Expenditure Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Coverage Ratio
-80.36 -103.20 -38.10 -37.60 -105.64
Operating Cash Flow to Sales Ratio
-336.09 0.00 0.00 0.00 -126.77
Free Cash Flow Yield
-41.13%-89.20%-87.27%-44.24%-68.06%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
13.81 -1.10 -0.37 -1.89 -0.98
Price-to-Sales (P/S) Ratio
817.14 0.00 0.00 0.00 186.27
Price-to-Book (P/B) Ratio
4.02 6.15 0.39 0.40 0.12
Price-to-Free Cash Flow (P/FCF) Ratio
-2.43 -1.12 -1.15 -2.26 -1.47
Price-to-Operating Cash Flow Ratio
-3.13 -1.12 -1.15 -2.26 -1.47
Price-to-Earnings Growth (PEG) Ratio
0.13 0.01 >-0.01 0.02 0.02
Price-to-Fair Value
4.02 6.15 0.39 0.40 0.12
Enterprise Value Multiple
-1.73 -0.35 0.26 0.51 3.98
Enterprise Value
151.95M 40.09M -23.09M -18.71M -91.70M
EV to EBITDA
-1.73 -0.35 0.26 0.51 3.98
EV to Sales
791.42 0.00 0.00 0.00 -764.16
EV to Free Cash Flow
-2.35 -1.01 0.81 0.65 6.03
EV to Operating Cash Flow
-2.35 -1.01 0.81 0.65 6.03
Tangible Book Value Per Share
0.23 -1.02 3.63 5.60 75.49
Shareholders’ Equity Per Share
0.65 0.29 5.89 11.07 131.32
Tax and Other Ratios
Effective Tax Rate
-0.03 0.00 <0.01 0.06 0.02
Revenue Per Share
<0.01 0.00 0.00 0.00 0.08
Net Income Per Share
0.19 -1.64 -6.13 -2.33 -15.72
Tax Burden
0.97 1.00 0.99 0.94 0.98
Interest Burden
-0.20 0.94 1.00 1.00 1.00
Research & Development to Revenue
355.49 0.00 0.00 0.00 51.09
SG&A to Revenue
102.33 0.00 0.00 0.00 83.77
Stock-Based Compensation to Revenue
72.52 0.00 0.00 0.00 26.43
Income Quality
-49.37 0.34 0.32 0.84 0.67
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis